액소젠(AXGN)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $45.09 (-0.43%), 시가총액 $2.17B, 52주 최저~최고 $9.29 ~ $43.74.
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard
액소젠의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
액소젠의 현재 주가는 $45.09 (-0.43%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
액소젠의 시가총액은 약 $2.17B입니다.
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avanc